Functional ingredients
Functional ingredients
Category, provenance, supply format
The category, provenance and supply format of the functional ingredients AriBnC works with. Specifications, marker compounds, analytical methods, stability data and country-by-country regulatory files are provided individually after business verification.
- Individually recognised ingredient filings supported
- US NDI notifications supported
- Canada NHP product licence (NPN) application support
- EU novel food and health claim support
Ingredient work inside one organisation
Run on the same footing as our human studies and regulatory work
AriBnC is a KoNECT-registered CRO (April 2023) that runs human studies and regulatory work inside one organisation. Ingredient work follows the same structure, at the lab in the Yongin head office and at our UNIST Research Institute (the UNIST site of our Corporate Affiliated Research Institute).
We work with a number of ingredients
Two of them are introduced below. Others are discussed individually after business verification.
BCS-001F black cumin seed extract powder
A powdered extract from the seed of Nigella sativa L., holding Korean individually recognised ingredient status. The MFDS recognition number is 2025-3, granted on 7 February 2025, and the recognition is held by AriBnC Co., Ltd. On the certificate the ingredient is named black cumin extract (FJ).
BCS-001F overviewFrom our UNIST Research InstituteProbiotic strains
Strains developed by natural adaptation and selection (Naturally Adapted & Selected) at our UNIST Research Institute (opened June 2024). Three have been deposited for patent purposes with the Korean Collection for Type Cultures (KCTC) at the Korea Research Institute of Bioscience and Biotechnology; for one of them, NGM1-12-L209, a patent application has been filed (KR 10-2025-0215909; see Research record for its title). Characterisation data are released after business verification. A related patent application, ‘AI-based gut microbiome profile prediction and personalised probiotics’, was filed as KR 10-2025-0108178 in August 2025.
Naturally adapted probioticsAt a glance
Category, provenance and supply format of both ingredients
| Ingredient | Category and provenance | Supply format | Detailed data |
|---|---|---|---|
| BCS-001F | Plant seed extract (Nigella sativa L.) | Powder | Specification and analytical data after business verification |
| Naturally adapted probiotics | Three strains developed at our UNIST Research Institute, deposited at KCTC for patent purposes | To be agreed after business verification | Strain list, deposit numbers and characterisation data after business verification |
Specifications, marker compounds and analytical methods, stability data and country filing histories are released individually through the request form below.
How we work on ingredients
Ingredient work is split between the lab at the Yongin head office and the UNIST Research Institute. Yongin covers clinical and nonclinical study design, biostatistics, EDC build and operation, and CRF design. The UNIST Research Institute has handled probiotics and in-house lab-scale research since June 2024.
Regulatory scope is designed for Korea's MFDS, the US FDA (GRAS, NDI), Health Canada's NNHPD (NHP/NPN) and the EU (novel food Reg. 2015/2283, health claims Reg. 1924/2006, EFSA). Key engagements are listed below.
- Individually recognised ingredient filings supported
- US NDI notifications supported
- MOTIR industrial-innovation national R&D programme, 30-month agreement (June 2026)
- CRO contract with a US company, September 2026
Engagement types
Frequently asked questions
Can we get a sample or a quotation?
Tell us what it is for when you get in touch, and we will come back to you after discussing it internally.
Can we start from development, before there is an ingredient?
Yes — as a full-service engagement. We take it from the nonclinical stage (in vitro bioactivity, in vivo mechanism, specification, marker compound, process and analytical method, safety review) through the human study (clinical) to the MFDS submission (regulatory). The detailed scope is set out on the CRO services page.
Specifications and supply terms follow business verification. If you need to start further upstream, talk to us about a full-service scope running from nonclinical through to the dossier.